Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cytokeratin 6E Inhibitors

Cytokeratin 6E inhibitors are a class of compounds designed to specifically target cytokeratin 6E, a member of the cytokeratin family of intermediate filament proteins. Cytokeratins are crucial for the structural integrity and mechanical resilience of epithelial cells, where they form networks of filaments that support the cellular architecture. Cytokeratin 6E, a type II keratin, is typically expressed in epithelial tissues, particularly those undergoing rapid turnover or subjected to stress, such as the epidermis and hair follicles. It works by pairing with type I keratins to form strong, flexible intermediate filaments that help cells withstand mechanical forces and maintain their structural integrity. Inhibitors of cytokeratin 6E interfere with these processes by blocking its normal filament-forming capabilities.

Cytokeratin 6E contains conserved alpha-helical domains, which enable it to assemble into coiled-coil dimers with other cytokeratins. These dimers further polymerize into filaments that are integral to the cytoskeleton. Inhibitors of cytokeratin 6E are thought to disrupt these structural elements, either by preventing the protein from dimerizing with its partners or by destabilizing the filament networks it forms. This inhibition leads to altered cytoskeletal organization within epithelial cells, potentially affecting their ability to respond to mechanical stress. By modulating the activity of cytokeratin 6E, these inhibitors serve as valuable tools for studying how intermediate filaments contribute to the overall structure, dynamics, and mechanical properties of epithelial tissues. Understanding the impact of these inhibitors on cytokeratin networks can provide insight into the fundamental processes of cellular structure and function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid, a histone deacetylase inhibitor, may downregulate CK6E expression through the alteration of chromatin compaction, allowing for the suppression of keratin-associated gene transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

By inhibiting DNA methyltransferase, 5-Aza-2′-Deoxycytidine could lead to the demethylation of the CK6E gene promoter, resulting in the transcriptional silencing of this keratin gene.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram may decrease CK6E expression by hindering the NF-κB pathway, which is often involved in the transcriptional activation of various keratin genes.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib might reduce CK6E levels by disrupting proteasomal degradation pathways, leading to an accumulation of proteins that repress transcription factors critical for CK6E gene expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, by inhibiting mTOR signaling, could lead to a decrease in the overall protein synthesis rates, including the synthesis of CK6E.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol, as a cyclin-dependent kinase inhibitor, may disrupt cell cycle progression and consequently downregulate CK6E gene transcription.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 could decrease CK6E expression by inhibiting the PI3K/AKT pathway, which is known to contribute to the transcriptional regulation of various keratins.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

As an MEK inhibitor, PD 98059 has the potential to inhibit the MAPK/ERK signaling pathway, which may lead to a decrease in transcription factors that drive CK6E expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, could decrease CK6E expression by preventing the activation of AP-1 transcription factors that are implicated in keratin gene expression.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib could inhibit CK6E expression by blocking EGFR signaling, which may be involved in keratin gene transcription regulation.